دورية أكاديمية

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease

التفاصيل البيبلوغرافية
العنوان: Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
المؤلفون: Alexander, J, Selinger, CP, Powell, N
المساهمون: Pfizer Limited
المصدر: 988 ; 987
بيانات النشر: Elsevier
سنة النشر: 2021
المجموعة: Imperial College London: Spiral
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, POLYSACCHARIDE, Adolescent, Adult, Aged, 80 and over, COVID-19, COVID-19 Vaccines, Child, Humans, Immunization Schedule, Immunization, Secondary, Immunocompromised Host, Immunosuppressive Agents, Inflammatory Bowel Diseases, Middle Aged, Practice Guidelines as Topic, United Kingdom, Young Adult, British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
تدمد: 2468-1253
العلاقة: The Lancet Gastroenterology & Hepatology; http://hdl.handle.net/10044/1/92004Test
DOI: 10.1016/S2468-1253(21)00374-5
الإتاحة: https://doi.org/10.1016/S2468-1253Test(21)00374-5
http://hdl.handle.net/10044/1/92004Test
حقوق: © 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.B9E42895
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.B9E42895
927
3
Academic Journal
academicJournal
926.820373535156
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.B9E42895&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1016/S2468-1253(21)00374-5# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Alexander%2C+J%22">Alexander, J</searchLink><br /><searchLink fieldCode="AR" term="%22Selinger%2C+CP%22">Selinger, CP</searchLink><br /><searchLink fieldCode="AR" term="%22Powell%2C+N%22">Powell, N</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Pfizer Limited )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => 988 ; 987 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Elsevier )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Imperial College London: Spiral )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Science+%26+Technology%22">Science & Technology</searchLink><br /><searchLink fieldCode="DE" term="%22Life+Sciences+%26+Biomedicine%22">Life Sciences & Biomedicine</searchLink><br /><searchLink fieldCode="DE" term="%22Gastroenterology+%26+Hepatology%22">Gastroenterology & Hepatology</searchLink><br /><searchLink fieldCode="DE" term="%22POLYSACCHARIDE%22">POLYSACCHARIDE</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescent%22">Adolescent</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%2280+and+over%22">80 and over</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+Vaccines%22">COVID-19 Vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22Child%22">Child</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Immunization+Schedule%22">Immunization Schedule</searchLink><br /><searchLink fieldCode="DE" term="%22Immunization%22">Immunization</searchLink><br /><searchLink fieldCode="DE" term="%22Secondary%22">Secondary</searchLink><br /><searchLink fieldCode="DE" term="%22Immunocompromised+Host%22">Immunocompromised Host</searchLink><br /><searchLink fieldCode="DE" term="%22Immunosuppressive+Agents%22">Immunosuppressive Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Inflammatory+Bowel+Diseases%22">Inflammatory Bowel Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Practice+Guidelines+as+Topic%22">Practice Guidelines as Topic</searchLink><br /><searchLink fieldCode="DE" term="%22United+Kingdom%22">United Kingdom</searchLink><br /><searchLink fieldCode="DE" term="%22Young+Adult%22">Young Adult</searchLink><br /><searchLink fieldCode="DE" term="%22British+Society+of+Gastroenterology+Inflammatory+Bowel+Disease+section+and+the+Inflammatory+Bowel+Disease+Clinical+Research+Group%22">British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group</searchLink> )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => unknown )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 2468-1253 )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => The Lancet Gastroenterology & Hepatology; http://hdl.handle.net/10044/1/92004 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/S2468-1253(21)00374-5 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1016/S2468-1253(21)00374-5<br />http://hdl.handle.net/10044/1/92004 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => © 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/ )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.B9E42895 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1016/S2468-1253(21)00374-5 ) ) [Languages] => Array ( [0] => Array ( [Text] => unknown ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Science & Technology [Type] => general ) [1] => Array ( [SubjectFull] => Life Sciences & Biomedicine [Type] => general ) [2] => Array ( [SubjectFull] => Gastroenterology & Hepatology [Type] => general ) [3] => Array ( [SubjectFull] => POLYSACCHARIDE [Type] => general ) [4] => Array ( [SubjectFull] => Adolescent [Type] => general ) [5] => Array ( [SubjectFull] => Adult [Type] => general ) [6] => Array ( [SubjectFull] => Aged [Type] => general ) [7] => Array ( [SubjectFull] => 80 and over [Type] => general ) [8] => Array ( [SubjectFull] => COVID-19 [Type] => general ) [9] => Array ( [SubjectFull] => COVID-19 Vaccines [Type] => general ) [10] => Array ( [SubjectFull] => Child [Type] => general ) [11] => Array ( [SubjectFull] => Humans [Type] => general ) [12] => Array ( [SubjectFull] => Immunization Schedule [Type] => general ) [13] => Array ( [SubjectFull] => Immunization [Type] => general ) [14] => Array ( [SubjectFull] => Secondary [Type] => general ) [15] => Array ( [SubjectFull] => Immunocompromised Host [Type] => general ) [16] => Array ( [SubjectFull] => Immunosuppressive Agents [Type] => general ) [17] => Array ( [SubjectFull] => Inflammatory Bowel Diseases [Type] => general ) [18] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [19] => Array ( [SubjectFull] => Practice Guidelines as Topic [Type] => general ) [20] => Array ( [SubjectFull] => United Kingdom [Type] => general ) [21] => Array ( [SubjectFull] => Young Adult [Type] => general ) [22] => Array ( [SubjectFull] => British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Alexander, J ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Selinger, CP ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Powell, N ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pfizer Limited ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2021 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 24681253 ) [1] => Array ( [Type] => issn-locals [Value] => edsbas ) [2] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => 988 ; 987 [Type] => main ) ) ) ) ) ) )
IllustrationInfo